Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
1/20/2023
Funding for Biopharmaceuticals Plummeted in 2022 with Investments Flow...
1/20/2023
Look out, AbbVie and J&J. BeiGene's Brukinsa Just Scored A Key Leukemi...
1/20/2023
China Anti-Rheumatic Drug Market - Growing Prevalence of Rheumatic Pat...
1/20/2023
Drug R&D and Product Registration News Digest January 2023 (3)
1/19/2023
CDE Issues the Provisions for GLP Certification of Drug Non-Clinical R...
1/19/2023
CDE Issues the Guidelines for Clinical R&D of New Drugs for Chronic Ly...
1/19/2023
China Issues the Measures for Linking the Drug Administrative Law Enfo...
1/19/2023
NHC Issues Notice to Step Up Clinical Use Regulation of Pediatric Drug...
1/19/2023
After Ditching Promising Drug, Everest Medicines Bets on mRNA (The Bam...
1/19/2023
AbbVie, Novartis and More Win National Coverage in China Even as Pfize...
1/19/2023
Chinese Market Biosimilar Update (JDSupra)
1/18/2023
Lilly and AffaMed Enter Pact for Commercialization of Migraine Drug Ga...
1/18/2023
China Issues Notice to Encourage Foreign Capital to Set up R&D Centers...
1/18/2023
NHSA and MOHRSS Jointly Issues the 2022 National Drug Reimbursement Li...
1/18/2023
Moderna in Active Discussions with China to Supply COVID Vaccines
1/17/2023
Sinovent Pharma Sign Two Out-licensing Deals with METiS and AmMax Bio
1/17/2023
Entering J&J's Fiefdom, Luye Wins FDA Approval of Long-acting Schizoph...
1/16/2023
The China Imperative for Multinational Companies
1/16/2023
Prevalence, Awareness, Treatment and Control of Hypertension in China,...
1/16/2023
NMPA Announces Package Insert Revision of Sodium Carbosulfate Formulat...
1/16/2023
NHSA Holds 2023 National Healthcare Security Conference, Laying Out Po...
1/16/2023
CARsgen Thera and Huadong Medicine Forms Commercialization Partnership...
1/13/2023
HSMAP: Chinese MedPharm Industry Operations Report 2022
1/13/2023
PhIRDA: Early Stage Financing and Recent Startups Dominate Chinese Pha...
1/13/2023
NHC Issues 2nd Batch of the List of Drugs Subject To Focused State Rat...
1/13/2023
AstraZeneca, Genertec Meheco Sign Deal for COVID Therapy Evusheld in C...
1/13/2023
MNCs to Play Key Role in Improving Cardiovascular Disease Management A...
1/13/2023
Drug R&D and Product Registration News Digest January 2023 (2)
1/12/2023
Information Collection on the 8th VBP Officially Initiated
1/12/2023
Astellas Sues Qilu Pharma in the U.S. to Block Its Generic Bladder Dru...
Page:
115
/
775
Total number of articles:
23249
:
[First]
[<<]
[113]
[114]
[115]
[116]
[117]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit